Loader_Image
Close
Stop playing catch-up. Start watching ausbiz.
    00:01
    00:00

    Three big moves in seven weeks; how Kazia is turbocharging biotech innovation

    21 Apr 2021

    Kazia Therapeutics CEO James Garner is a very happy man. After securing the company's third key licence in seven weeks, he tells us about the why's and how's.

    MedTech
    Following
    CEOs & MDs
    Following

    Experts & companies in this video

    Kazia Therapeutics logo

    Kazia Therapeutics

    Pharmaceuticals
    FollowFollowing
    prev
    next

    Related Videos

    LATEST
    04:09
    Now Playing

    Three big moves in seven weeks; how Kazia is turbocharging biotech innovation

    05:53

    Veris cashes in on the infrastructure push

    05:25

    Green Critical Minerals targets tech titans

    04:33

    Race Oncology's trial gains speed

    05:26

    Plenti-ful gains

    07:00

    The small cap adviser competing with the big players

    06:34

    Lumos's $500M deal lighting the way in diagnostics

    10:07

    Navigating growth: NGI’s $131B milestone

    04:50

    Funding the flow: Saunders’ $30M Aqua Metro deal

    06:57

    Glass Act: ClearVue's solar vision

    prev
    next